Latest TUBINGEN Stories
- Boehringer Ingelheim obtains exclusive global rights for development and commercialization of CureVac's investigational therapeutic cancer vaccine CV9202 INGELHEIM and TUBINGEN, Germany,
- Triggered by ongoing and very successful multi-year collaboration TUBINGEN, Germany, July 1, 2014 /PRNewswire/ -- CureVac, a German clinical-stage biopharmaceutical company, today
An unusual posthumous honor for physicist Max Planck: Biologists in Tubingen working with Ralf J. Sommer have named a newly discovered nematode after the German Nobel laureate.
- To fire mitraille at.